Kimberly-Clark Acquires Kenvue in $49 Billion Deal
Consumer giant Kimberly-Clark, maker of Huggies diapers and Kleenex tissues, is buying Kenvue, the company behind Tylenol and Band-Aids, in a $49 billion merger.
The deal comes amidst controversy surrounding Tylenol, after the Trump administration linked its active ingredient, acetaminophen, to autism, despite lacking clear scientific evidence. Kenvue has denied these claims as "simply false".
- Tylenol
- Band-Aids
- Listerine
- Neutrogena
- Aveeno
"a global health and wellness leader"
According to Kimberly-Clark CEO Mike Hsu, the merger will create a global health and wellness leader, adding a new range of consumer brands to the company's portfolio.
Author's summary: Kimberly-Clark buys Kenvue for $49 billion.